MyAverix Finance
ST · Healthcare
Genetic Analysis AS (GEAN)
Diagnostics & Research
Genetic Analysis AS (GEAN) is listed on ST in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for GEAN
Genetic Analysis AS (GEAN) — FAQ
What is GEAN's P/E ratio?
The price-to-earnings (P/E) ratio for Genetic Analysis AS (GEAN) is 18.00 (data as of 2026-05-23).
Does Genetic Analysis AS pay a dividend?
Dividend yield is not available in the current snapshot for Genetic Analysis AS (GEAN). Check the MyAverix Finance app for the latest dividend data.
What sector is Genetic Analysis AS in?
Genetic Analysis AS (GEAN) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is GEAN listed on?
GEAN is listed on ST.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.